Ivermectin use in children below 15 kg: potential benefits for onchocerciasis and scabies elimination programmes
Br J Dermatol
.
2020 Apr;182(4):1064.
doi: 10.1111/bjd.18685.
Epub 2019 Dec 25.
Authors
R Colebunders
1
,
S T Wafula
1
,
A Hotterbeekx
1
,
J N Siewe-Fodjo
1
Affiliation
1
Global Health Institute, University of Antwerp, Antwerp, Belgium.
PMID:
31693749
DOI:
10.1111/bjd.18685
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Child
Humans
Infant
Ivermectin
Onchocerciasis*
Scabies*
Substances
Ivermectin
Grants and funding
671055/ERC_/European Research Council/International